Valiant Laboratories Limited (NSE:VALIANTLAB)
India · Delayed Price · Currency is INR 114.13
+5.43 (5.00%)
Sep 8, 2026, 3:25 PM IST
Valiant Laboratories Market Cap
Valiant Laboratories has a market cap or net worth of 6.2 billion as of September 8, 2026. Its market cap has increased by 36.42% in one year.
Market Cap
6.20B
Enterprise Value
6.33B
Revenue
3.06B
Ranking
n/a
PE Ratio
38.71
Stock Price
114.13
ChartMarket Cap Chart
Since October 6, 2023, Valiant Laboratories's market cap has decreased from 7.40B to 6.20B, a decrease of -16.20%. That is a compound annual growth rate of -5.86%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 8, 2026 | 6.20B | 63.04% |
| Dec 31, 2025 | 3.80B | -21.26% |
| Dec 31, 2024 | 4.83B | -35.84% |
| Dec 29, 2023 | 7.53B | 1.73% |
| Oct 6, 2023 | 7.40B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Windlas Biotech | 23.24B |
| Sakar Healthcare | 22.56B |
| Beta Drugs | 22.39B |
| Jagsonpal Pharmaceuticals | 15.96B |
| Sigachi Industries | 13.27B |
| Anlon Healthcare | 8.33B |
| Amanta Healthcare | 7.53B |
| Bafna Pharmaceuticals | 7.00B |